Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema

NCT01919801 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
118
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shire

Collaborators